NCT06074536

Brief Summary

The purpose of this study is to compare the effect of face-to-face training of general practitioners on the implementation of a shared decision (in the context of colorectal cancer screening), versus current practice (i.e. without training in the patient-centered approach).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Mar 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Mar 2024Nov 2027

First Submitted

Initial submission to the registry

September 21, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

March 6, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3.2 years

First QC Date

September 21, 2023

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Measurement of the achievement oh the shared decision shared decision making in CRC screening using the patient shared a self-decision-making questionnaire (SDM-Q9), validated in French

    comparison of the mean of the SDM-Q9 between each arm of the study from 0 (weak shared decision) to 100 (strong shared decision). We will compare the average of the SDM-Q9 between each arm of the study

    6 to 8 months after after patient nclusion (carrying out the screening test)

Secondary Outcomes (3)

  • Evaluate the effect of training on the CRC screening rate

    Measurements taken 6 months after the last patient was included in the trial, i.e. no later than 18 months after the start of the trial

  • Confronting the shared decision made by the patient regarding the completion of CRC screening

    Measurements taken 6 months after the last patient was included in the trial, i.e. no later than 18 months after the start of the trial

  • Explore understanding of the shared decision process among general practitioners and patients

    Data collected immediately after the inclusion visit

Study Arms (2)

Interventional arm

EXPERIMENTAL

The recruited GPs will be randomized into 2 parallel groups (interventional and control). Following this randomization, the GPs from the interventional group will undergo face-to-face training to the patient-centered approach.

Procedure: patient-centered approach training

Control arm

NO INTERVENTION

The GPs of the control group will take care the patient according to current screening recommendations and procedures organized by the colorectal cancer (CCR) mass screening.

Interventions

face to face training of general practitioner of interventional arm

Interventional arm

Eligibility Criteria

Age50 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 50 to 74:
  • Eligible for organized CRC screening,
  • Having declared as attending clinician a general practitioner investigator of the study
  • ✓ Consulting their attending clinician for the duration of the study,
  • AND able and willing to comply with all trial requirements
  • \- ✓ Screened for CRC less than 2 years ago
  • Not eligible for organized CRC screening:
  • History of adenomas or CRC:
  • \- Family (1st degree)
  • Personal history of IBD:
  • Crohn's disease
  • Ulcerative colitis)
  • Hereditary predispositions:
  • Familial adenomatous polyposis
  • Hereditary non-polyposis colorectal cancer (Lynch syndrome)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cabinet de groupe pluriprofessionnel

Soisy-sous-Montmorency, 95230, France

RECRUITING

Study Officials

  • Isabelle AUGER-AUBIN, Pr

    cabinet de groupe pluriprofessionnel 40 rue Carnot 95230 Soisy-Sous-Montmorency

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patient not informed of the randomization arm to which their general practitioner enrolled
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patient-centered face-to-face training for General Practitioners on implementation of a shared decision
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2023

First Posted

October 10, 2023

Study Start

March 6, 2024

Primary Completion (Estimated)

May 6, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations